Abstract:OBJECTIVE:Applying multiplex PCR and multiplex ligation-dependent probe amplification (MLPA) in a clinical setting to detect deletions and duplications in the Duchenne/Becker muscular dystrophy (DMD/BMD) gene not only for patients, but also for identification of possible carriers and prenatal diagnosis. METHODS:Multiplex PCR was used first in patients clinically diagnosed with DMD/BMD to examine 26 exons for a large deletion in the two hot regions of the dystrophin gene. For patients without a deletion detected in the aforementioned regions, MLPA was used to further examine all 79 exons to determine whether a deletion in the remaining non-hot regions or any duplication was present. A similar approach was applied to suspected carriers. In requested prenatal diagnosis cases, specific PCR was used to detect deletions, while MLPA was applied to detect duplications. RESULTS:Multiplex PCR was used to examine 26 exons within the two hot regions in the Dystrophin gene for 22 patients with DMD; 13 (13/22) had multi-exon deletions. For the 9 patients without deletions in the 26 exons, MLPA was used to examine 79 exons. 3 patients had duplications, 1 patient had a single deletion in exon 18, and no deletions or duplications could be detected in the remaining 5 patients. Of the 16 carriers, 2 out of the 3 that had family history had deletions, while the other 13 carriers were mothers of affected children who were sporadic patients without family history. Of them, 8 mothers were carriers for either deletions or duplications. For prenatal diagnosis, 9 fetuses were examined (one case was twins). Of them, 2 fetuses had familial deletions or duplications detected. These results were verified after induced abortion. In 7 fetuses, no deletions or duplications were detected and all developed into children. CONCLUSION:Multiplex PCR can detect 92.86% of deletions and is useful for prenatal diagnosis of deletions because it is simple, reliable and inexpensive. It can be the first choice in DMD/BMD gene diagnosis. MLPA is important for detecting deletions in non-hot regions/exons and duplications in the DMD/BMD gene, as well as for carrier detection.

Dystrophin Detection by Immunofiuorescent Technique for Diagnosing Duchenne Muscular Dystrophy/Becker Muscular Dystrophy and Duchenne Muscular Dystrophy Carrier

A Sensitive, Reproducible and Objective Immunofluorescence Analysis Method of Dystrophin in Individual Fibers in Samples from Patients with Duchenne Muscular Dystrophy

Diagnostic Value of Neuronal Nitric Oxide Synthase Antibody for Clinically Suspected Becker Muscular Dystrophy

Detection of duplication mutation and carriers of Duchenne/Becker muscular dystrophy by multiplex ligation-dependent probe amplification quantitative

Structural Analysis of DMD Gene and Its Clinical Application in Chinese.I.Bgl II Exon-Containing Fragment, RFLP and Carrier Detection

Changes of Dystrophin Expression in Muscle of Patients with DMD and Its Relevance to Clinical Pathology

Combined screening of multiplex polymerase chain reaction and denaturing high-performance liquid chromatography in Duchenne muscular dystrophy with mutation deletion

Targeted Next-Generation Sequencing As a Comprehensive Test for Patients with and Female Carriers of DMD/BMD: a Multi-Population Diagnostic Study

Population-Wide Duchenne Muscular Dystrophy Carrier Detection by CK and Molecular Testing

Ultrastructural features of skeletal muscle in the patients with Duchenne/Becker muscular dystrophy

[Clinical and Pathological Features of 50 Children with Duchenne's Muscular Dystrophy].

A preliminary study of gene products encoded by disease genes of muscular dystrophy

Development of a Comprehensive Real-Time PCR Assay for Dystrophin Gene Analysis and Prenatal Diagnosis of Chinese Families.

Identify female carriers and de novo mutations in deletional Duchenne/Becker muscular dystrophy families.

Comprehensive Genetic Diagnosis of Patients with Duchenne/Becker Muscular Dystrophy (DMD/BMD) and Pathogenicity Analysis of Splice Site Variants in the DMD Gene

[Mutation Screening of the Dystrophin Gene in 14 Chinese Duchenne/Becker Muscular Dystrophy Patients Without Gross Deletions].

X-chromosome Inactivation Pattern of Amniocytes Predicts the Risk of Dystrophinopathy in Fetal Carriers of DMD Mutations.

[Combining approach with multiplex PCR and MLPA to detect deletion and duplication in DMD patients, carriers, and prenatal diagnosis].

The Trefoil with Single Fruit Sign in Muscle Magnetic Resonance Imaging is Highly Specific for Dystrophinopathies

Clinical, Molecular Pathological and Genetic Analysis of a Chinese Family with Dystrophinopathy

Application of trigeminy-PCR in prenatal diagnosis of Duchenne/Becker muscular dystrophy